Prestige Consumer Healthcare
271 hedge funds and large institutions have $3.07B invested in Prestige Consumer Healthcare in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 92 increasing their positions, 99 reducing their positions, and 17 closing their positions.
159% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 17
9% more funds holding
Funds holding: 248 → 271 (+23)
0.51% less ownership
Funds ownership: 101.39% → 100.88% (-0.51%)
6% less capital inflows, than outflows
Capital inflows: $181M | Capital outflows: $192M
7% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 99
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$14M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$7.94M |
| 3 |
Renaissance Technologies
New York
|
+$6.7M |
| 4 |
BlackRock
New York
|
+$6.61M |
| 5 |
Bridgeway Capital Management
Houston,
Texas
|
+$6.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$68.4M |
| 2 |
Champlain Investment Partners
Burlington,
Vermont
|
-$13.9M |
| 3 |
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
-$11.8M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.02M |
| 5 |
Millennium Management
New York
|
-$6.89M |
PBH Hedge Fund Activity: Q4 2021 in Review
271 of the 6,523 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2021, worth a combined $3.07B — up 7.6% from $2.85B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new PBH positions and 17 closed out — a net gain of 27 holders — while 92 added to existing stakes and 99 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $14M. The largest seller was Wells Fargo, cutting an estimated $68.4M.
- 271 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2021, up from 248 in Q3 2021.
- Funds reported $3.07B of Prestige Consumer Healthcare stock for Q4 2021, up 7.6% quarter-over-quarter.
- 44 funds opened new Prestige Consumer Healthcare positions in Q4 2021 and 17 closed out, a net change of +27 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2021 was Goldman Sachs, an estimated $14M added.
- The largest Prestige Consumer Healthcare seller in Q4 2021 was Wells Fargo, an estimated $68.4M sold.
Based on aggregated 13F filings for Q4 2021.